Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response

Publisher： Karger

E-ISSN： 1664-5553|5|3|155-161

ISSN： 2235-1795

Source： Liver Cancer, Vol.5, Iss.3, 2016-05, pp. : 155-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C

By Takashimizu Shinji  

Clinical Journal of Gastroenterology, Vol. 4, Iss. 3, 2011-06 ,pp. : 167-173

Springer Publishing Company

Access to resources Recommend Favorite

Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review

By Saito Masaya  

Clinical Journal of Gastroenterology, Vol. 5, Iss. 2, 2012-04 ,pp. : 119-126

Springer Publishing Company

Access to resources Recommend Favorite

Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin

By Perrella A.   Sbreglia C.   Atripaldi L.   Esposito C.   D'Antonio A.   Perrella O.  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 2, 2010-02 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite

Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 447-455

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

By Tateyama Masakuni   Yatsuhashi Hiroshi   Taura Naota   Motoyoshi Yasuhide   Nagaoka Shinya   Yanagi Kenji   Abiru Seigo   Yano Koji   Komori Atsumasa   Migita Kiyoshi   Nakamura Minoru   Nagahama Hiroyasu   Sasaki Yutaka   Miyakawa Yuzo   Ishibashi Hiromi  

Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 92-100

Springer Publishing Company

Access to resources Recommend Favorite